Satoshi Ishihara

Saitama International Medical Center

Papers

1

Total Citations

6

H-Index

1

About

Satoshi Ishihara is a cancer genomics researcher whose work focuses on the molecular mechanisms driving clear cell renal cell carcinoma (ccRCC), with a particular emphasis on the Von Hippel-Lindau (VHL) tumor suppressor pathway. His most cited study, "Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential VHL Mutations Underlie Multifocal ccRCC" (2022, 6 citations), provides critical insights into how chromosomal rearrangements and subsequent VHL mutations contribute to the development of multiple, independent tumor sites within the same kidney. By elucidating the sequence of genetic events—from derivative chromosome 3 loss to differential VHL inactivation—Ishihara’s work advances our understanding of tumor heterogeneity and clonal evolution in ccRCC. His research has direct implications for precision oncology, helping to explain why some patients develop aggressive, multifocal disease. Though early in his career, Ishihara’s contributions are already shaping how researchers conceptualize the interplay between structural genomic alterations and tumor suppressor gene dysfunction in kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential<i>VHL</i>Mutations Underlie Multifocal ccRCC
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Saitama International Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago